Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1200 of 2873 entries
View as:

Barriers Associated With Timely Adjuvant Chemotherapy Administration in Patients With Invasive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04087057 Org: User:
Start: 08/23/19 End: 04/16/24 Due: 04/16/25

Viral Specific T Cell Therapy for COVID-19 Related Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT04742595 Org: User:
Start: 12/18/20 End: 09/20/24 Due: 09/20/25

Assessment of Symptom-Related Cytokines in Lung and Gastrointestinal (GI) Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00502502 Org: User:
Start: 11/30/02 End: 07/31/10 Due: 07/31/11

Complete Decongestive Therapy (CDT) for Treatment of Head and Neck Lymphedema

Phase: N/A Priority: Normal
NCT ID: NCT00951470 Org: User:
Start: 10/31/12 End: - Due: -

Temozolomide and SCH66336 for Recurrent Glioblastoma Multiforme

Phase: N/A Priority: Normal
NCT ID: NCT00038493 Org: User:
Start: 09/21/01 End: 08/01/05 Due: 08/01/06

Three-Dimensional Fluoroscopic Guidance During Transbronchial Cryobiopsy

Phase: N/A Priority: Normal
NCT ID: NCT05059691 Org: User:
Start: 03/30/21 End: 05/11/23 Due: 05/11/24

Guadecitabine With or Without Idarubicin or Cladribine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02096055 Org: User:
Start: 04/04/14 End: 11/24/20 Due: 11/24/21

Study of Adoptive Cellular Therapy Using Autologous T Cells Transduced With Lentivirus to Express a CD33 Specific Chimeric Antigen Receptor in Patients With Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT03126864 Org: User:
Start: 08/04/17 End: 10/10/19 Due: 10/10/20

Recombinant Human Interleukin-7 (CYT107) to Promote T-Cell Recovery After Cord Blood Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT03600896 Org: User:
Start: 11/30/18 End: 11/30/24 Due: 11/30/25

Lung Cancer STARS Trial - STARS Revised Clinical Trial Protocol: Stereotactic Ablative Radiotherapy (SABR) in Stage I Non-small Cell Lung Cancer Patients Who Can Undergo Lobectomy

Phase: N/A Priority: Normal
NCT ID: NCT02357992 Org: User:
Start: 04/05/10 End: 09/17/21 Due: 09/17/22

Robotic Bronchoscopy With Cone CT and Indocyanine Green to Aid Removal of Lung Lesions in Patients With Stage I Non-small Cell Lung Cancer or Lung Metastases, REPLACING Study

Phase: N/A Priority: Normal
NCT ID: NCT04987281 Org: User:
Start: 01/26/22 End: 12/27/23 Due: 12/27/24

Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)

Phase: N/A Priority: Normal
NCT ID: NCT01821963 Org: User:
Start: 04/30/13 End: 02/28/14 Due: 02/28/15

APPSPIRE App in Preventing Students From Smoking

Phase: N/A Priority: Normal
NCT ID: NCT01967082 Org: User:
Start: 10/16/13 End: 01/08/20 Due: 01/08/21

Data Collection of Demographics and Perioperative Care of Patients Undergoing Laparoscopic Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00490126 Org: User:
Start: 06/15/06 End: 09/18/18 Due: 09/18/19

PEG Interferon Alpha 2B and Low-Dose Ara-C in Early Chronic Phase CML

Phase: N/A Priority: Normal
NCT ID: NCT00303290 Org: User:
Start: 01/31/00 End: 11/30/14 Due: 11/30/15

5-Azacytidine With Lenalidomide in Patients With High Risk Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT01038635 Org: User:
Start: 12/31/09 End: 11/30/15 Due: 11/30/16

Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03096782 Org: User:
Start: 10/13/17 End: 09/20/22 Due: 09/20/23

Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00068432 Org: User:
Start: 12/31/03 End: 07/31/05 Due: 07/31/06

Oral Clofarabine Study in Patients With Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00299156 Org: User:
Start: 03/31/06 End: 12/31/12 Due: 12/31/13

Cloretazine (VNP40101M) With Hematopoietic Cell Transplantation for Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00521859 Org: User:
Start: 08/31/07 End: 12/31/10 Due: 12/31/11

Glioblastoma Multiforme (GBM) Proton vs. Intensity Modulated Radiotherapy (IMRT)

Phase: N/A Priority: Normal
NCT ID: NCT01854554 Org: User:
Start: 05/17/13 End: 10/13/21 Due: 10/13/22

Doctor-Recommended Home-Based Exercise Program or Relaxation Training in Improving Physical Function and Controlling Symptoms in Patients With Stage IV or Recurrent Colon Cancer That Cannot Be Removed By Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00985400 Org: User:
Start: 11/05/10 End: 03/31/23 Due: 03/31/24

CASAD for Severe Diarrhea in the Emergency Department

Phase: N/A Priority: Normal
NCT ID: NCT02018653 Org: User:
Start: 12/31/13 End: 08/31/14 Due: 08/31/15

MEK Inhibitor 162 Relapsed and/or Refractory Acute Myeloid Leukemia (AML) and Poor Prognosis, Not Suitable for or Unwilling to Receive Standard Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02089230 Org: User:
Start: 08/27/14 End: 06/05/19 Due: 06/05/20

Azacitidine (AZA) in Minimal Residual Disease (MRD) Chronic Myeloid Leukemia (CML)

Phase: N/A Priority: Normal
NCT ID: NCT01460498 Org: User:
Start: 08/08/12 End: 08/07/19 Due: 08/07/20